pegozafermin

5 Promising MASH Therapies That Could Follow Madrigal’s Rezdiffra
BioSpace
Mon, 04/15/24 - 11:24 am
MASH
NASH
Madrigal Pharmaceuticals
Rezdiffra
Ionis Pharmaceuticals
ION224
Altimmune
pemvidutid
89Bio
pegozafermin
Viking Therapeutics
VK2809
Aligos Therapeutics
ALG-055009
89bio wins EMA priority status for MASH candidate pegozafermin
Clinical Trials Arena
Thu, 03/28/24 - 11:21 am
89Bio
Europe
EMA
pegozafermin
MASH
89bio kicks off Phase III trial for pegozafermin in MASH
Clinical Trials Arena
Tue, 03/12/24 - 06:51 pm
89Bio
clinical trials
pegozafermin
MASH
NASH
89bio Unveils Bullish Long-Term Data for NASH Candidate
BioSpace
Tue, 11/28/23 - 10:21 am
89Bio
NASH
clinical trials
pegozafermin
89Bio Enlivened by Nash success
EP Vantage
Thu, 03/23/23 - 09:50 am
89Bio
NASH
Akero Therapeutics
pegozafermin
INTERCEPT
Madrigal Pharmaceuticals
89bio to initiate Phase III trials for pegozafermin in severe hypertriglyceridaemia
Clinical Trials Arena
Wed, 01/11/23 - 10:47 am
89Bio
pegozafermin
clinical trials
hypertriglyceridemia
89bio’s home run fails to excite
EP Vantage
Wed, 06/29/22 - 10:35 am
89Bio
NASH
pegozafermin
hypertriglyceridemia
89bio gains a little more confidence in NASH treatment with new hormone data
Fierce Biotech
Sun, 03/27/22 - 03:52 pm
89Bio
NASH
liver disease
pegozafermin